期刊文献+

治疗性乙型肝炎疫苗研究进展 被引量:7

The advance on immunotherapy of hepatitis B by anti HBV vaccine
在线阅读 下载PDF
导出
摘要 乙肝疫苗多用于预防乙型肝炎病毒(HBV)。近年来,人们的研究重点转移到了针对慢性乙肝病毒携带者和慢性乙肝患者的治疗性疫苗的开发上。本文就治疗性乙肝疫苗的分类、机制及临床疗效加以综述。 Though prophylactic hepatitis B vaccine very popular,more and more people studies on immunotherapy using anti-HBV vaccine to chronic carriers of HBV and chronic HBV patients.This article reviewed its classification,the mech-anism of immnotherapy and the probably clinic effcts.
出处 《生物技术通讯》 CAS 2004年第3期289-291,共3页 Letters in Biotechnology
关键词 乙型肝炎 疫苗 病毒 治疗 HBV hepatitis B virus therapeutic vaccine
  • 相关文献

参考文献23

  • 1闻玉梅,何丽芳,瞿涤,马张妹,姚忻.重组治疗性乙型肝炎疫苗(YIC)的实验研究[J].中国工程科学,1999,1(1):38-42. 被引量:16
  • 2姚伟,郑菊梅,孟秀园,苏庆华,王玺珍.治疗性乙肝疫苗研究及疗效考核[J].微生物学免疫学进展,1998,26(3):50-53. 被引量:7
  • 3Livingston BD, Alexander J, Crimi C, et al. Altered helper T lym phocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans [J].Immunol, 1999,162:3088
  • 4Le Borgne S, Mancini M, Le Grand R, et al. In vivo induction of specific cytoxic T lymphocytes in mice and rhesus macaques im mynized with DNA vector encoding and HIV epitope fused with hepatitis B surfaceantigen[J]. Virology, 1998,240:304
  • 5Kane M. Global programme for control of hepatitis B infection [J].Vaccine, 1995,13:(S1)S47
  • 6Heathcote J, Mchutchison J, Lee S, et al. A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hep atitis B virus[J]. Hepatology, 1999,30:531
  • 7Boni C, Bertoletti A, Penna A, et al. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B[J]. J Clin In vest, 1998,102:968
  • 8Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo[J]. Science, 1990,247:1465
  • 9Mancini M, Davis HL, Tiollais P, et al. DNA-based immuniza-tion against the envelope proteins of the hepatitis B virus[J]. J Biotechnol, 1996,44:47
  • 10Loirat D, Li Z, Mancini M, et al. Muscle-specific expression of hepatitis B surface antigen:no effect on DNA-raised immune re sponses[J]. Virology, 1999,260:74

二级参考文献32

  • 1闻玉梅.治疗性疫苗的研究进展[J].中华微生物学和免疫学杂志,1996,16(3):155-158. 被引量:24
  • 2[1]Kuttner G,Kramer A,Schmidtke G,et al.Characterization of neutral-izing anti-pre-S1 and anti-pre-S2 (HBV) monoclonal antibodies andtheir fragments[J].Mol Immunol,1999,36(10):669-683.
  • 3[2]Chisari FV,Ferrari C.Hepatitis B virus immunopathogenesis[J].Annu Rev Immunol,1995,13(1):29-60.
  • 4[3]Pumpens P,Grens E.HBV Core particles as a carrier for B cell/T cell epitopes[J].Intervirology,2001,44(2-3):98-114.
  • 5[4]Tam JP,Lu YA.Vaccine engineering:enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes[J].Proc Natl Acad Sci USA,1989,86(23):9084-9088.
  • 6[5]Yang W,Waine GJ,Mcmanus DP.Antibodies to Schistosoma japonicum paramyosin induced by nucleic-acid vaccination[J].Biochem Biophys Res Commun,1995,212(3):1029-1039.
  • 7[6]Itoh Y,Takai E,Ohnuma H,et al.A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA:protective efficacy in chimpanzees[J].Proc Natl Acad Sci USA,1986,83(23):9174-9178.
  • 8[7]Milich DR,Mclachlan A,Chisari FV,et al.Two distinct but overlapping antibody binding sites in the pre-S(2) region of HBsAg localized within 11 continuous residues[J].J Immunol,1986,137(7-8):2703-2710.
  • 9[8]Makela PH.Vaccines,coming of age after 200 years[J].FEMS Microbiol Rev,2000,24(1):9-20.
  • 10[9]Pumpens P,Borisova GP,Grens E,et al.Hepatitis B virus core particles as epitope carriers[J].Intervirology,1995,38(1-2):63-74.

共引文献35

同被引文献82

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部